Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-24-024040

Options or other derivatives

  • Chief Operating Officer acquired 276,523 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Morgen Eric · Chief Operating Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-09-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +4,952 4,952 I
2024-04-17 Grant or award : show line 2 in the form Stock Option (Right to Buy) +257,973 257,973 D
2024-04-17 Grant or award : show line 3 in the form Stock Option (Right to Buy) +13,598 13,598 I
Loading xslF345X05/form4-09272024_080956.xml…